Beatrice Detti, Muhammed Baki, Carlotta Becherini, Calogero Saieva, Daniele Scartoni, Irene Giacomelli, Laura Trombetta, Cristina Muntoni, Emanuela Olmetto, Giulio Francolini, Ana Turkaj, Juliana Topulli, Cinzia Ciabatti, Giulio Carta, Linda Poggesi, Camilla Delli Paoli, Francesca Terziani, Roberta Grassi, Lorenzo Livi
PURPOSE: Prostatectomy, radiotherapy and watchful waiting are the main therapeutic options available for local stage of prostate cancer (PCa). We report our experience on 394 patients affected by prostate cancer primarily treated with high-dose, image-guided, IMRT, focusing on gastrointestinal, genitourinary toxicities and biochemical control. METHODS: From July 2003 to August 2014, 394 patients were treated with radical high-dose radiotherapy (HDRT) for prostate cancer; the mean total radiation dose was 79 Gy in standard fractions...
May 2019: La Radiologia Medica